NASDAQ: GOVX
Geovax Labs Inc Stock Ownership - Who owns Geovax Labs?

Insider buying vs selling

Have Geovax Labs Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kelly T. McKee Jr.Chief Medical Officer2025-08-071,107$0.67
$741.69Buy
John W. SharkeyVP Business Development2025-04-106,000$0.99
$5.94kBuy
John N. Spencer Jr.Director2025-04-1010,000$0.98
$9.80kBuy
David A. DoddPresident CEO2025-04-0110,000$1.08
$10.80kBuy
Mark ReynoldsCFO2025-03-316,800$1.08
$7.34kBuy

1 of 1

GOVX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GOVX insiders and whales buy or sell their stock.

GOVX Shareholders

What type of owners hold Geovax Labs Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
University Emory911.17%231,070,253$158.51MInsider
Andrew J. Kandalepas84.03%21,310,065$14.62MInsider
Robert T. McNally5.18%1,314,119$901.49kInsider
Harriet L. Robinson4.63%1,173,726$805.18kInsider
Donald G. Hildebrand4.22%1,071,400$734.98kInsider
Peter M. Tsolinas1.70%431,734$296.17kInsider
Ubs Group Ag0.79%200,257$137.38kInstitution
Vanguard Group Inc0.45%115,156$79.00kInstitution
Geode Capital Management LLC0.42%106,955$73.37kInstitution
Morgan Stanley0.20%50,120$34.38kInstitution

1 of 3

GOVX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GOVX0.21%99.79%Net BuyingNet Buying
LITS12.00%88.00%
EDSA18.81%81.19%Net Buying
IBIO8.49%91.51%Net Buying
BLRX0.00%0.00%

Geovax Labs Stock Ownership FAQ

Who owns Geovax Labs?

Geovax Labs (NASDAQ: GOVX) is owned by 2.18% institutional shareholders, 1,011.55% Geovax Labs insiders, and 0.00% retail investors. University Emory is the largest individual Geovax Labs shareholder, owning 231.07M shares representing 911.17% of the company. University Emory's Geovax Labs shares are currently valued at $161.06M.

If you're new to stock investing, here's how to buy Geovax Labs stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.